Numerous studies have consistently demonstrated that HMGB1, acting as a “late‐phase” inflammatory mediator, drives the inflammatory cascade in diverse pathologies including trauma, sepsis, radiation‐induced injury, autoimmune diseases, and neurodegenerative disorders. This evidence concerns the gene HMGB1 and Sepsis.